Join
Live feed
·
FDARegulatoryvia Quantisnow
Novavax Inc. logo
Pfizer Inc. logo

August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

ByQuantisnow·Wall Street's wire, on your screen.
NVAX· Novavax Inc.PFE· Pfizer Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NVAX (Novavax Inc.), PFE (Pfizer Inc.) and more on Quantisnow.

August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente. | Quantisnow